Headache and Migraine

The smartphone-delivered progressive muscle relaxation may be a useful and affordable form of evidence-based therapy that a primary care physician can prescribe to their patients.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 28, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 27, 2020.

The professor of neurology at the NYU Langone Grossman School of Medicine detailed the ways the COVID-19 pandemic impacted mental health of frontline clinicians.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 20, 2020.

The NDA is supported by the phase 3 STOP 301 trial, which included more than 5650 migraine attacks in patients with or without aura.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 13, 2020.

The professor of neurology at the NYU Langone Grossman School of Medicine outlined the confusion on whether deaths are related to COVID-19, a symptom associated, or previously unidentified underlying condition.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 6, 2020.

The company’s implantable neurostimulation system uses its bioelectronic foil technology and aims to meet the needs of those with chronic migraine for whom therapy has failed.

The professor of neurology at the NYU Langone Grossman School of Medicine gave her thoughts on how her recently published data on neurologic disorders in COVID-19 compare to previously reported data.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending October 31, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 30, 2020.